211 related articles for article (PubMed ID: 16908863)
21. RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.
Li P; Schwarz EM; O'Keefe RJ; Ma L; Boyce BF; Xing L
J Bone Miner Res; 2004 Feb; 19(2):207-13. PubMed ID: 14969390
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.
Kobayashi K; Takahashi N; Jimi E; Udagawa N; Takami M; Kotake S; Nakagawa N; Kinosaki M; Yamaguchi K; Shima N; Yasuda H; Morinaga T; Higashio K; Martin TJ; Suda T
J Exp Med; 2000 Jan; 191(2):275-86. PubMed ID: 10637272
[TBL] [Abstract][Full Text] [Related]
23. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
Itoh K; Udagawa N; Katagiri T; Iemura S; Ueno N; Yasuda H; Higashio K; Quinn JM; Gillespie MT; Martin TJ; Suda T; Takahashi N
Endocrinology; 2001 Aug; 142(8):3656-62. PubMed ID: 11459815
[TBL] [Abstract][Full Text] [Related]
24. Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors.
Sugatani T; Alvarez UM; Hruska KA
J Cell Biochem; 2003 Sep; 90(1):59-67. PubMed ID: 12938156
[TBL] [Abstract][Full Text] [Related]
25. TNF‑α and RANKL promote osteoclastogenesis by upregulating RANK via the NF‑κB pathway.
Luo G; Li F; Li X; Wang ZG; Zhang B
Mol Med Rep; 2018 May; 17(5):6605-6611. PubMed ID: 29512766
[TBL] [Abstract][Full Text] [Related]
26. The possible role of TGF-beta-induced suppressors of cytokine signaling expression in osteoclast/macrophage lineage commitment in vitro.
Fox SW; Haque SJ; Lovibond AC; Chambers TJ
J Immunol; 2003 Apr; 170(7):3679-87. PubMed ID: 12646633
[TBL] [Abstract][Full Text] [Related]
27. Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis.
Park H; Jung YK; Park OJ; Lee YJ; Choi JY; Choi Y
J Immunol; 2005 Dec; 175(11):7193-201. PubMed ID: 16301623
[TBL] [Abstract][Full Text] [Related]
28. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.
Kalliolias GD; Zhao B; Triantafyllopoulou A; Park-Min KH; Ivashkiv LB
Arthritis Rheum; 2010 Feb; 62(2):402-13. PubMed ID: 20112358
[TBL] [Abstract][Full Text] [Related]
30. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
[TBL] [Abstract][Full Text] [Related]
31. Functional identification of three receptor activator of NF-kappa B cytoplasmic motifs mediating osteoclast differentiation and function.
Liu W; Xu D; Yang H; Xu H; Shi Z; Cao X; Takeshita S; Liu J; Teale M; Feng X
J Biol Chem; 2004 Dec; 279(52):54759-69. PubMed ID: 15485878
[TBL] [Abstract][Full Text] [Related]
32. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation.
Ikeda F; Nishimura R; Matsubara T; Tanaka S; Inoue J; Reddy SV; Hata K; Yamashita K; Hiraga T; Watanabe T; Kukita T; Yoshioka K; Rao A; Yoneda T
J Clin Invest; 2004 Aug; 114(4):475-84. PubMed ID: 15314684
[TBL] [Abstract][Full Text] [Related]
33. β-Arrestin 1 in Thyrotropin Receptor Signaling in Bone: Studies in Osteoblast-Like Cells.
Boutin A; Gershengorn MC; Neumann S
Front Endocrinol (Lausanne); 2020; 11():312. PubMed ID: 32508750
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population.
Nagata N; Kitaura H; Yoshida N; Nakayama K
Bone; 2003 Oct; 33(4):721-32. PubMed ID: 14555278
[TBL] [Abstract][Full Text] [Related]
35. Dexamethasone enhances osteoclast formation synergistically with transforming growth factor-beta by stimulating the priming of osteoclast progenitors for differentiation into osteoclasts.
Takuma A; Kaneda T; Sato T; Ninomiya S; Kumegawa M; Hakeda Y
J Biol Chem; 2003 Nov; 278(45):44667-74. PubMed ID: 12944401
[TBL] [Abstract][Full Text] [Related]
36. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
37. Cell adhesion signaling regulates RANK expression in osteoclast precursors.
Mochizuki A; Takami M; Miyamoto Y; Nakamaki T; Tomoyasu S; Kadono Y; Tanaka S; Inoue T; Kamijo R
PLoS One; 2012; 7(11):e48795. PubMed ID: 23139818
[TBL] [Abstract][Full Text] [Related]
38. Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss.
Sun L; Vukicevic S; Baliram R; Yang G; Sendak R; McPherson J; Zhu LL; Iqbal J; Latif R; Natrajan A; Arabi A; Yamoah K; Moonga BS; Gabet Y; Davies TF; Bab I; Abe E; Sampath K; Zaidi M
Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4289-94. PubMed ID: 18332426
[TBL] [Abstract][Full Text] [Related]
39. TSH-Mediated TNFα Production in Human Fibrocytes Is Inhibited by Teprotumumab, an IGF-1R Antagonist.
Chen H; Shan SJ; Mester T; Wei YH; Douglas RS
PLoS One; 2015; 10(6):e0130322. PubMed ID: 26087256
[TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
Balga R; Wetterwald A; Portenier J; Dolder S; Mueller C; Hofstetter W
Bone; 2006 Aug; 39(2):325-35. PubMed ID: 16580896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
